Codify — Article

Bill narrows technology considered for effluent guidelines to U.S.-commercial options

Amends Clean Water Act §304(b)(1)(B) to require EPA to consider total cost only for technologies 'commercially available in the United States,' tightening what counts when setting effluent limitation guidelines.

The Brief

The Water Quality Technology Availability Act amends 33 U.S.C. 1314(b)(1)(B) to insert the phrase "technology that is commercially available in the United States in relation to" into the statutory provision governing EPA’s effluent limitation guideline (ELG) guidance. In practice, the bill directs EPA to limit the universe of technologies it weighs — and the "total cost of application" it considers — to technologies already commercially available within the United States.

This is a narrow textual change with outsized practical effect: it reduces the statutory basis for EPA to rely on foreign, experimental, or otherwise non‑commercial technologies when setting national ELGs. That shift raises immediate questions about rulemaking scope, data burdens, litigation risk, and the future role of emerging and pilot-scale water treatment solutions in federal standard‑setting.

At a Glance

What It Does

The bill amends Federal Water Pollution Control Act section 304(b)(1)(B) by inserting the phrase "technology that is commercially available in the United States in relation to" into the guidance language EPA uses when developing effluent limitation guidelines. It thereby narrows the class of technologies EPA must consider when assessing the "total cost of application."

Who It Affects

EPA rulemakers, industries regulated by ELGs (manufacturing sectors, wastewater dischargers, POTWs), domestic water‑technology manufacturers, and stakeholders who develop or deploy pilot/emerging treatment technologies.

Why It Matters

By legally anchoring consideration to U.S.-commercial technologies, the bill increases predictability for regulated sources and domestic vendors but may exclude foreign or experimental options that could lower pollutant loads. That change could reshape the technologies reflected in future ELGs and shift the evidentiary record needed for rulemakings and potential litigation.

More articles like this one.

A weekly email with all the latest developments on this topic.

Unsubscribe anytime.

What This Bill Actually Does

The statutory change is short but targeted: it replaces the more open phrase "technology in relation to" with "technology that is commercially available in the United States in relation to" in the clause of the Clean Water Act that guides how EPA develops effluent limitation guidelines. The practical consequence is that EPA should limit its consideration — and its cost analyses — to technologies already being sold and deployed in the U.S., rather than relying on laboratory, pilot, or foreign solutions that are not yet commercial here.

For rulewriters, this creates a clearer, narrower evidentiary perimeter. When EPA assembles the administrative record for an ELG, it will rely on data about technologies that have a commercial footprint in the U.S.: vendors offering products, deployment case studies, cost schedules for capital and operations, and performance claims grounded in commercial installations.

That generally raises the bar for demonstrating feasibility from the agency side but also simplifies cost estimation because domestic market data are easier to standardize and verify.The change also changes incentives in the marketplace. Domestic manufacturers gain an advantage in federal standard setting because their technologies are more likely to be considered; developers of emerging, pilot-stage, or foreign-based technologies may find it harder to have their solutions reflected in ELGs until they establish a U.S. commercial presence.

For permittees and industry trade groups, the bill reduces the risk that EPA will set limitations based on technologies that they cannot reasonably acquire or apply in the U.S. environment.Finally, the amendment is procedural in form—no funding, timelines, or new compliance obligations are added—but its legal narrowing will influence the content of future ELGs, the evidence EPA solicits and credits, and the contours of judicial review. Courts will likely be asked to resolve disputes over what counts as "commercially available in the United States" and what components of "total cost of application" the agency must include in its analysis.

The Five Things You Need to Know

1

The bill amends 33 U.S.C. 1314(b)(1)(B) by inserting the exact phrase "technology that is commercially available in the United States in relation to" into the statutory guidance for effluent limitation guidelines.

2

The statutory insertion narrows the set of technologies EPA must consider when evaluating the "total cost of application" to those with a commercial presence in the United States, excluding purely experimental or foreign‑only options.

3

The bill contains no accompanying funding, effective‑date specification, or definitional text (for example, it does not define "commercially available"), leaving those thresholds to EPA interpretation or litigation.

4

Because the change governs the substantive guidance EPA uses to derive ELGs, it can alter which control technologies appear in national standards and therefore which technologies regulated facilities must reasonably consider or install.

5

The amendment is narrowly drafted and does not alter other statutory factors in ELG development (such as practicability, performance, or horsepower thresholds), but it may substantially affect the administrative record the agency builds and the types of cost data required.

Section-by-Section Breakdown

Every bill we cover gets an analysis of its key sections. Expand all ↓

Section 1

Short title

Provides the act's short title, "Water Quality Technology Availability Act." This is a standard caption provision with no operative effect on implementation; it functions only for citation.

Section 2

Amendment to Federal Water Pollution Control Act — narrow technology scope

Operative change: amends 33 U.S.C. 1314(b)(1)(B) by replacing the phrase "technology in relation to" with "technology that is commercially available in the United States in relation to." The text change directly limits the statutory universe of technologies EPA should consider when preparing guidelines that inform effluent limitation guideline rulemakings.

Practical implications arise because EPA's ELG rules historically draw on a mixture of commercially deployed systems, pilot projects, and international designs. The amendment requires EPA to anchor cost and feasibility analyses to technologies with a U.S. commercial footprint, which will influence information requests, sampling of facilities, and the sort of vendor documentation the agency solicits.

At scale

This bill is one of many.

Codify tracks hundreds of bills on Environment across all five countries.

Explore Environment in Codify Search →

Who Benefits and Who Bears the Cost

Every bill creates winners and losers. Here's who stands to gain and who bears the cost.

Who Benefits

  • Domestic water‑technology manufacturers: The change increases the likelihood that technologies already sold in the U.S. will be the basis for ELGs, giving established domestic vendors an advantage in federal standards and procurement.
  • Regulated industrial dischargers and trade associations: Facilities face lower risk that EPA will set limits based on inaccessible foreign or experimental technologies, improving predictability for capital planning and compliance costs.
  • State permitting authorities and permittees: States and local permitting authorities gain a clearer reference point for what constitutes available control technology, reducing disputes over feasibility and enforceability tied to non‑U.S. or pilot technologies.

Who Bears the Cost

  • EPA and its rulewriters: The agency will need to refine its data collection and analytical frameworks to justify that considered technologies are "commercially available in the United States," potentially increasing administrative burdens and litigation exposure over definitions and record sufficiency.
  • Developers of emerging or foreign technologies: Companies that operate only abroad or are still in pilot stages will find it harder to have their solutions factored into national ELGs until they establish a U.S. commercial presence.
  • Environmental NGOs and communities pushing for more stringent standards: If high‑performance but non‑commercial or foreign technologies are excluded, advocates may have fewer legal footholds to push for tighter ELGs based on those innovations.

Key Issues

The Core Tension

The central dilemma is how to balance regulatory realism for U.S. dischargers and vendors against flexibility to consider the best environmental technology wherever it exists: insisting on a U.S. commercial presence makes standards more practicable for regulated sources but risks locking in a narrower set of technologies and slowing adoption of potentially superior but non‑commercial or foreign options.

The amendment is deceptively simple: a single inserted phrase will prompt a cascade of interpretive questions. First, the bill does not define "commercially available in the United States." Does a single U.S. pilot installation qualify?

Must a technology be sold by a U.S. vendor, or is sale by a foreign firm into the U.S. market sufficient? Courts will likely be asked to resolve such line‑drawing contests, and EPA rulewriters must choose administrable bright lines or face prolonged litigation.

Second, the bill emphasizes "total cost of application," but does not specify which cost components belong in that total. Capital, installation, operation and maintenance, lifecycle replacement, permitting, residuals management, and opportunity costs can all be argued either way; the omission leaves room for divergent agency practices and stakeholder disputes.

A second tension is policy trade‑offs between domestic economic protection and environmental performance. Anchoring ELGs to U.S.-commercial technologies protects regulated entities from infeasible standards, but it also reduces the statutory space for EPA to encourage faster deployment of potentially better foreign or nascent solutions.

That could slow diffusion of certain high‑performance controls into U.S. markets. Finally, because the bill adds no resources or procedural guidance, EPA may respond with more detailed data demands in rulemakings (raising compliance costs for industry) or with conservative interpretations that could blunt environmental stringency — both outcomes that stakeholders will contest.

Try it yourself.

Ask a question in plain English, or pick a topic below. Results in seconds.